Efficacy and Safety Study of Desmoteplase to Treat Acute Ischemic Stroke (DIAS-4)
Status:
Terminated
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
The purpose of the study is to determine whether desmoteplase is effective and safe in the
treatment of patients with acute ischaemic stroke when given within 3 to 9 hours from onset
of stroke symptoms.